TrialScientific reports2021

The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24).

Xue-Lian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.